Wellington Management Group
PALI icon

Wellington Management Group’s Palisade Bio PALI Stock Holding History

Wellington Management Group’s Portfolio PALI Stock Details PALI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.08M Buy
+2,904,911
New +$5.28M ﹤0.01% 1402

Other funds holding PALI

Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
BGI
B Group Inc Dallas, Texas $135M AUM 80% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

Wellington Management Group's PALI Position: Q1 2026 in Review

Wellington Management Group opened a new position in Palisade Bio (PALI) in Q1 2026: 2,904,911 shares worth $5.08M. The stake represents ﹤0.01% of the portfolio and ranks #1402 among its holdings.

96 funds tracked by Wall St. Rank hold PALI as of Q1 2026.

  • Wellington Management Group held 2,904,911 shares of Palisade Bio worth $5.08M as of Q1 2026.
  • Palisade Bio was a new Wellington Management Group position in Q1 2026.
  • Palisade Bio made up ﹤0.01% of Wellington Management Group's portfolio in Q1 2026, its #1402 holding.
  • 96 funds tracked by Wall St. Rank held Palisade Bio as of Q1 2026.

Based on Wellington Management Group's 13F filing for Q1 2026, filed 15 May 2026.